BRIEF published on 06/26/2026 at 17:05, 2 months 15 days ago Résultats de l'assemblée générale annuelle 2026 de Darwin AG Stratégie D'entreprise Dividende Assemblée Générale Annuelle Approbation Des Actionnaires Changement De Nom D'entreprise
PRESS RELEASE published on 06/26/2026 at 17:00, 2 months 15 days ago Darwin AG Announces Results of the 2026 Annual General Meeting Darwin AG announces results of the 2026 Annual General Meeting, including approval of resolutions, dividend distribution, and change of name to Novogenia AG Dividend Distribution Resolutions Darwin AG 2026 Annual General Meeting Novogenia AG
BRIEF published on 05/12/2026 at 09:05, 4 months ago Darwin AG annonce un doublement de ses revenus en 2025 Croissance Des Revenus Investissements Informatiques Tests Génétiques Résultats Financiers 2025 Darwin AG
BRIEF published on 05/12/2026 at 09:05, 4 months ago Darwin AG Reports Doubling of Revenue in 2025 Revenue Growth Genetic Testing IT Investments 2025 Financial Results Darwin AG
PRESS RELEASE published on 05/12/2026 at 09:00, 4 months ago Darwin AG publishes financial figures and provides business update for 2025 Darwin AG publishes financial figures with positive net income for 2025, marking a transition to profitable growth. The company emphasizes international expansion and innovation Profitable Growth Financial Figures International Expansion Positive Net Income Darwin AG
BRIEF published on 04/09/2026 at 10:05, 5 months 3 days ago Darwin AG participera à des conférences financières clés en 2026 Résultats Financiers Investissement Dans Le Secteur De La Santé Darwin AG Investir 2026 Forum Des Actions
BRIEF published on 04/09/2026 at 10:05, 5 months 3 days ago Darwin AG to Attend Key Financial Conferences in 2026 Financial Results Healthcare Investment Equity Forum Darwin AG Invest 2026
PRESS RELEASE published on 04/09/2026 at 10:00, 5 months 3 days ago Darwin AG to Present at Invest 2026 in Stuttgart and the Equity Forum in Frankfurt Darwin AG to present at Invest 2026 in Stuttgart & Equity Forum in Frankfurt, sharing its equity story & recent developments in spring 2026. Topics: precision health, personalized solutions Personalized Solutions Equity Forum Precision Health Darwin AG Invest 2026
BRIEF published on 03/18/2026 at 10:05, 5 months 25 days ago Darwin AG lance un test multicancer pour le dépistage précoce du cancer. Diagnostic Non Invasif Darwin AG Bilan Multicancer Dépistage Précoce Du Cancer Marché De La Biopsie Liquide
BRIEF published on 03/18/2026 at 10:05, 5 months 25 days ago Darwin AG Launches Multi-Cancer Check for Early Cancer Detection Early Cancer Detection Darwin AG Multi-Cancer Check Liquid Biopsy Market Non-invasive Diagnostics
Published on 09/12/2026 at 02:35, 11 hours 6 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 41 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 36 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 16 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 41 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 11 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 26 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 31 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 56 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 26 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
